Comprehensive Healthcare Systems, Inc. (TSXV:CHS)
Canada · Delayed Price · Currency is CAD 0.4050
0.00 (0.00%)
Aug 5, 2026, 3:56 PM EST
TSXV:CHS Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 1.05 | 0.04 | 0.01 | 0.02 | 0.4 | 3.4 |
Cash & Short-Term Investments | 1.05 | 0.04 | 0.01 | 0.02 | 0.4 | 3.4 |
Cash Growth | 488.67% | 420.81% | -67.78% | -94.06% | -88.20% | 64.79% |
Accounts Receivable | 0.12 | 0.37 | 0.22 | 0.35 | 0.46 | 0.33 |
Other Current Assets | 0.44 | 0.07 | 0.06 | 0.03 | 0.24 | 0.04 |
Total Current Assets | 1.62 | 0.48 | 0.29 | 0.4 | 1.09 | 3.77 |
Net Property, Plant & Equipment | 0.54 | 0.4 | 0.34 | 0.5 | 0.95 | 0.34 |
Other Long-Term Assets | 0.04 | 0.04 | 0.02 | 0.07 | 0.07 | - |
Total Assets | 2.21 | 0.93 | 0.65 | 0.97 | 2.11 | 4.11 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 2.82 | 3.72 | 4.14 | 3.89 | 2.63 | 1.37 |
Short-Term Debt | 0.11 | 0.13 | 0.34 | - | - | 0.99 |
Current Portion of Long-Term Debt | 0.44 | 1.8 | 1.5 | 1.36 | 0.27 | 0.37 |
Current Portion of Leases | 0.47 | 0.46 | 0.1 | 1.07 | 0.46 | 0.09 |
Unearned Revenue | 0.76 | 0.72 | 0.35 | 0.44 | 0.54 | 0.38 |
Other Current Liabilities | 0.03 | 0.03 | 0.1 | - | - | - |
Total Current Liabilities | 4.63 | 6.86 | 6.52 | 6.75 | 3.9 | 3.2 |
Long-Term Debt | 1.24 | 0.06 | 0.06 | 0.06 | 0.86 | - |
Long-Term Leases | 0.19 | 0.22 | 0.51 | - | 0.5 | 0.3 |
Total Long-Term Liabilities | 1.44 | 0.28 | 0.56 | 0.06 | 1.36 | 0.3 |
Total Liabilities | 6.07 | 7.14 | 7.08 | 6.81 | 5.26 | 3.5 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 19.15 | 17.47 | 15.36 | 15.36 | 14.87 | 13.3 |
Additional Paid-in Capital | 3.13 | 1.96 | 1.71 | 1.69 | 1.3 | 1.51 |
Accumulated Other Comprehensive Income | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Retained Earnings | -26.15 | -25.66 | -23.51 | -22.9 | -19.32 | -14.21 |
Shareholders' Equity | -3.86 | -6.22 | -6.43 | -5.84 | -3.15 | 0.6 |
Total Liabilities & Equity | 2.21 | 0.93 | 0.65 | 0.97 | 2.11 | 4.11 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 2.46 | 2.67 | 2.5 | 2.48 | 2.08 | 1.76 |
Net Cash (Debt) | -1.41 | -2.63 | -2.49 | -2.46 | -1.68 | 1.64 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -0.06 | -0.15 | -0.40 | -0.40 | -0.46 | 1.08 |
Book Value | -3.86 | -6.22 | -6.43 | -5.84 | -3.15 | 0.6 |
Book Value Per Share | -0.15 | -0.35 | -1.04 | -0.95 | -0.86 | 0.40 |
Tangible Book Value | -3.86 | -6.22 | -6.43 | -5.84 | -3.15 | 0.6 |
Tangible Book Value Per Share | -0.15 | -0.35 | -1.04 | -0.95 | -0.86 | 0.40 |